Total Funding
35
62
Total FundingVenture - Series Unknown raised
Growth Score 35 in past quarter
-2 pts
Heat Score 62 in past quarter
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
101844
Neogen TC is helping to develop a cancer immune T cell therapy based on an innovative technology based on immune cell therapy.
About the Company
Neogentc is developing an anti-cancer immune T-cell therapy based on a new antigen discovery platform that goes beyond inaccurate predictions and an innovative immune cell therapy-based technology that binds to actual immune cells.